Brent D. Wilson, M.D., Ph.D., F.A.C.C., is an Assistant Professor of Medicine at the University of Utah where he serves as Director of the Cardiovascular Center, Director of Cardiology Clinical Services, and Interim Director of the Echocardiography Laboratory. Prior to joining the University of Utah in 2009, Dr. Wilson served as Co-Director of Intermountain Healthcare’s Cardiac Imaging – Advanced Diagnostic Center. Dr. Wilson graduated with an Honors Degree in Biochemistry from the University of Utah in 1992 and then attended medical school at Stanford University. He also received a Ph.D. in Genetics from Stanford University and is the author of numerous publications. Dr. Wilson completed Internal Medicine Residency and Cardiology Fellowship at the University of Utah, as well as a fellowship in Advanced Cardiac Imaging. Dr. Wilson enjoys applying state-of the-art cardiac imaging technologies to patient care and has built a large clinical practice in Utah.
1. Weis, J.R., Pitas, R.E., Wilson, B.D., and G.M. Rodgers. (1991). “Oxidized low-density lipoprotein increases cultured human endothelial cell tissue factor activity and reduces protein C activation.” FASEB Journal 5(10): 2459-2465.
2. Wilson, B.D., Pitas, R.E., and G.M. Rodgers. (1992). “Regulation of endothelial cell protein C activation by native and oxidized low density lipoprotein.” Seminars in Thrombosis and Hemostasis 18(1): 11-17.
3. Gubler, D.B., Wilson, B.D., Parker, C.J., and G.M. Rodgers. (1993). “Regulation of endothelial cell protein C activation and fibrinolysis by procoagulant albumin.” Thrombosis Research 70(6): 459-469.
4. Fryer, R.H.,Wilson, B.D., Gubler, D.B., Fitzgerald, L.A., and G.M. Rodgers. (1993). “Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells.” Arteriosclerosis and Thrombosis 13(9): 1327-1333.
5. Wilson, B.D., Ollmann, M.M., Kang, L., Stoffel, M., Bell, G.I., and G.S. Barsh. (1995). “Structure and function of ASP, the human homolog of the mouse agouti gene.” Human Molecular Genetics 4(2): 223-230.
6. Yang, Y.K., Ollmann, M.M., Wilson, B.D., Dickinson, C., Yamada, T., Barsh, G.S., and I. Gantz. (1997). “Effects of recombinant agouti-signaling protein on melanocortin action.” Molecular Endocrinology 11(3): 274-280.
7. Wilson, B.D.*, Ollmann, M.M.*, Yang, Y.K., Kerns, J.A., Chen, Y., Gantz, I., and G.S. Barsh. *co-first authors. (1997). “Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein.” Science 278(5335): 135-138.
8. Ollmann, M.M., Lamoreux, M.L., Wilson, B.D., and G.S. Barsh. (1998). “Interaction of agouti protein with the melanocortin-1 receptor in vitro and in vivo.” Genes and Development 12(3): 316-330.
9. Wilson, B.D.*, Bagnol, D.*, Kaelin, C.B., Ollmann, M.M., Gantz, I., Watson, S. J., and G. S. Barsh. *co-first authors. (1999). “Physiological and anatomical circuitry between agouti-related protein and leptin signaling.” Endocrinology 140(5): 2387-2397.
10. Wilson, B.D., Ollmann, M.M., and G.S. Barsh. (1999). “The role of agouti-related protein in regulating body weight.” Molecular Medicine Today 5(6): 250-256.
11. Barsh, G.S., Ollmann, M.M., Wilson, B.D., Miller, K.A., and T.M. Gunn. (1999). “Molecular pharmacology of agouti protein in vitro and in vivo.” Annals of the New York Academy of Science 885: 143-152.
12. Barsh, G.S., Gunn, T.M., He, L., Wilson B.D., Lu, X., Gantz, I., and S. Watson. (2000). “Neuroendocrine regulation by the Agouti/Agrp-melanocortin system.” Endocrine Research 26(4): 571.
13. Chamberland, D.L., Wilson, B.D., and L.K. Weaver. (2004). “Transient cardiac dysfunction in acute carbon monoxide poisoning.” American Journal of Medicine 117(8): 623-625.
14. Wilson B.D.*, Ii, M.*, Park, K.W.*, Suli, A., Kock, G.A.H., Sorensen, L.K., Suh, W., Larrieu-Lahargue, F., Urness, L.D., Thomas, K.R., Chien, C.B., Losordo, D.W., and D.Y. Li. *co-first authors. (2006). “Netrins promote developmental and therapeutic angiogenesis.” Science 313(5787):640-644.
15. Wilson, B.D., and S.E. Litwin. (2007). “Tissue Doppler Imaging: Beautiful Noise.” Current Cardiology Reviews, 3(1):81-90.
16. Pack, N.A., DiBella, E.V.R., Wilson, B.D., and C.J. McGann. (2008) “Quantitative Myocardial Distribution Volume from Dynamic Contrast-Enhanced Perfusion MRI.” Magnetic Resonance Imaging 26: 532-542.
17. Wilson, B.D., Gibson, C.C., Sorensen, L.K., Guilhermier, M.Y., Clinger, M, Kelley, L.L., Shiu, Y.T., Li, D.Y. (2011) “Novel Approach for Endothelializing Vascular Devices: Understanding and Exploiting Elastin-Endothelial Interactions.” Ann Biomed Eng. 39(1):337-46.
18. McGann, C., Kholmovski, E., Blauer, J., Vijayakumar, S., Haslam, T., Cates, J., DiBella, E., Burgon, N., Wilson, B., Alexander, A., Prastawa, M., Daccarett, M., Vergara, G., Akoum, N., Parker, D., MacLeod, R, Marrouche, N. (2011) “Dark regions of no-reflow on late gadolinium enhancement magnetic resonance imaging result in scar formation after atrial fibrillation ablation.” J Am Coll Cardiol. 2011 Jul 5;58(2):177-85.
19. Hamilton, S.G., McGann, C.J., and B.D. Wilson. (2012). “Noninvasive Diagnosis of Chemotherapy Related Cardiotoxicity.” Current Cardiology Reviews, in press.